Pralidoxime

Any

Inj 25 mg per ml, 20 ml ampouleNew ZealandFunded

In other countries

The same active substances on other registers, the same brand first.

ContrathionItaly · Polvere e solvente per soluzione per infusione endovenosa · Serb S.A.SSame form
Oxidote 1GM VialSaudi Arabia · Tabuk Pharmaceutical Manufacturing Co./ Dammam PlantSame form
PAM-A INJECTION 500 mg/ampouleSingapore · 500 mg/ampoule · injection, powder, lyophilized, for solution · Shoei Universal Corporation Pte LTDSame form
Protopam ChlorideUnited States · 1GM/VIAL · injectable · Baxter Hlthcare CorpSame form
Pralidoxime ChlorideUnited States · 1GM/VIAL, 300MG/ML · injectable · Baxter Hlthcare CorpSame form
Protopam Chloride Inj 1GMCanada · 1 G / VIAL · Powder For Solution · Ayerst LaboratoriesSame substance
Protopam Chloride - (PWS 1G/Vial)

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Pralidoxime

Any

Inj 25 mg per ml, 20 ml ampouleNew ZealandFunded

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Canada · 1 G / VIAL · Powder For Solution · Wyeth Canada

PretavaSaudi Arabia · Hikma Italia SPA

Pralidoxime Chloride (Autoinjector)United States · 600MG/2ML · solution · Meridian Medcl Techn

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

PHARMAC, New Zealand

New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/HML/archive/2026/2026-10-01/HML_2026-10-01.xml; October 2026; published 2026-10-01; acquired 2026-10-13T22:49:54.923639+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.

Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Pralidoxime
Dosage form: Inj 25 mg per ml, 20 ml ampoule
Register: New Zealand (PHARMAC)
Status: Funded
Status in the register: Funded by PHARMAC
Procedure: Hospital Medicines List
Supply: Funded (PHARMAC)